Ataga KI - Search Results

1

The Evolving Landscape of Drug Therapies for Sickle Cell Disease.

Rai P, Desai PC, Ataga KI. Rai P, et al. Among authors: ataga ki. Hematol Oncol Clin North Am. 2022 Dec;36(6):1285-1312. doi: 10.1016/j.hoc.2022.06.008. Hematol Oncol Clin North Am. 2022. PMID: 36400544 Review.

2

Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial.

Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP; Sickle Cell Disease Clinical Research Network (SCDCRN). Peters-Lawrence MH, et al. Contemp Clin Trials. 2012 Mar;33(2):291-7. doi: 10.1016/j.cct.2011.11.018. Epub 2011 Dec 2. Contemp Clin Trials. 2012. PMID: 22155024 Free PMC article. Clinical Trial.

3

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.

Hines PC, Zen Q, Burney SN, Shea DA, Ataga KI, Orringer EP, Telen MJ, Parise LV. Hines PC, et al. Among authors: ataga ki. Blood. 2003 Apr 15;101(8):3281-7. doi: 10.1182/blood-2001-12-0289. Epub 2002 Dec 27. Blood. 2003. PMID: 12506027 Free article.

4

Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes.

Brittain JE, Han J, Ataga KI, Orringer EP, Parise LV. Brittain JE, et al. Among authors: ataga ki. J Biol Chem. 2004 Oct 8;279(41):42393-402. doi: 10.1074/jbc.M407631200. Epub 2004 Jul 29. J Biol Chem. 2004. PMID: 15292185 Free article.

5

Renal abnormalities in sickle cell disease.

Ataga KI, Orringer EP. Ataga KI, et al. Am J Hematol. 2000 Apr;63(4):205-11. doi: 10.1002/(sici)1096-8652(200004)63:4<205::aid-ajh8>3.0.co;2-8. Am J Hematol. 2000. PMID: 10706765 Free article. Review.

6

Hypercoagulability in sickle cell disease: a curious paradox.

Ataga KI, Orringer EP. Ataga KI, et al. Am J Med. 2003 Dec 15;115(9):721-8. doi: 10.1016/j.amjmed.2003.07.011. Am J Med. 2003. PMID: 14693325 Review.

7

Pulmonary hypertension in sickle cell disease.

Ataga KI, Sood N, De Gent G, Kelly E, Henderson AG, Jones S, Strayhorn D, Lail A, Lieff S, Orringer EP. Ataga KI, et al. Am J Med. 2004 Nov 1;117(9):665-9. doi: 10.1016/j.amjmed.2004.03.034. Am J Med. 2004. PMID: 15501204

8

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP. Ataga KI, et al. Br J Haematol. 2006 Jul;134(1):109-15. doi: 10.1111/j.1365-2141.2006.06110.x. Br J Haematol. 2006. PMID: 16803576 Free article.

9

Hypercoagulability in sickle cell disease: new approaches to an old problem.

Ataga KI, Key NS. Ataga KI, et al. Hematology Am Soc Hematol Educ Program. 2007:91-6. doi: 10.1182/asheducation-2007.1.91. Hematology Am Soc Hematol Educ Program. 2007. PMID: 18024615 Review.

10

Hypercoagulability in sickle cell disease and beta-thalassemia.

Singer ST, Ataga KI. Singer ST, et al. Among authors: ataga ki. Curr Mol Med. 2008 Nov;8(7):639-45. doi: 10.2174/156652408786241366. Curr Mol Med. 2008. PMID: 18991650 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page